Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

Status:
Completed

Trial end date:
2018-10-30

Target enrollment:

Participant gender:

This study evaluates the use of topical ABI-1968 cream, in the treatment of cervical precancerous lesions in adult women.

Phase 1

Antiva Biosciences